NGS + Antibiotic Recommendation
OtherNGS results in addition to recommended antibiotic therapy made by infectious disease pharmacist
NCT Number: NCT04404855
This is a randomized controlled clinical study evaluating the use of next-generation sequencing (NGS) to improve antibiotic prescribing before ureteroscopy or percutaneous nephrolithotomy.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Audie Murphy VA Hospital, San Antonio, Texas, United States
NGS will be performed on voided urine collected as routine care approximately 30 days prior to surgery. Results will be presented to Infectious Disease pharmacist within 48-72 hours to help select the most appropriate antibiotics, and independently as part of routine care, surgeons will choose the antibiotic that they would use in each case, while the Infectious Disease pharmacists would select their optimum choice. Approximately 220 subjects will be randomly assigned in a 1:1 ratio to receive either NGS antibiotic recommendation or standard of care (SOC) prophylaxis prescribed treatment. Subjects assigned to standard of care will have urine cultures sent for analysis, and the physician will choose antibiotics based on results as per usual practice. Subjects assigned to the NGS group, in addition to routine urine culture results, will have NGS urine culture results sent to an investigational drrug (ID) pharmacist, and recommendations will be shared with the physician to determine the antibiotic selection. The physician will ultimately decide the appropriate antibiotics to prescribe. Approximately 7-14 days after surgery, the research staff will conduct a telephone call to ask about any post-operative infections, complications, and any additional antibiotics that were prescribed.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
NGS results in addition to recommended antibiotic therapy made by infectious disease pharmacist
Subjects will have a standard of care urine culture and prophylactic antibiotic prescribed per routine care.
Time frame: One to two weeks after surgery (approximately 100 days from baseline)
Number of participants that develop post surgical infection
Time frame: Within 30 days of urine culture and date of surgery (approximately 100 days from baseline)
The number of participants who required their antibiotic treatment to be augmented (additional antibiotic given) or escalated (broader-spectrum antibiotic chosen).
The University of Texas Health Science Center at San Antonio
Other
Randomized Clinical Trial Using Next Generation Microbial Sequencing to Direct Antibiotic Selection Before Kidney Stone Lithotripsy Using an Interprofessional Model
Acronym: ACCESS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04519294
Calculi, Female Urogenital Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT06269783
Calculi, Female Urogenital Diseases
University Park, Pennsylvania, United States
View Trial DetailsNCT05701098
Calculi, Female Urogenital Diseases
San Diego, California, United States
View Trial DetailsNCT06615713
Calculi, Female Urogenital Diseases
Nadiād, India
View Trial Details